BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1569 related articles for article (PubMed ID: 22488538)

  • 21. [The incidence and risk factors for heterogeneous vancomycin intermediate Staphylococcus aureus].
    Feng NN; Wang Q; Song YL; He LX; Zhou CM; Xie HM; Li HY
    Zhonghua Nei Ke Za Zhi; 2013 Apr; 52(4):318-22. PubMed ID: 23925360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients.
    Kratzer C; Rabitsch W; Hirschl AM; Graninger W; Presterl E
    Eur J Haematol; 2007 Nov; 79(5):405-9. PubMed ID: 17714506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals.
    Sader HS; Jones RN; Rossi KL; Rybak MJ
    J Antimicrob Chemother; 2009 Nov; 64(5):1024-8. PubMed ID: 19744978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sensitivity to vancomycin and teicoplanin of coagulase-negative staphylococci isolated from clinical specimens].
    Młynarczyk G; Młynarczyk A; Luczak M; Jeljaszewicz J
    Med Dosw Mikrobiol; 1999; 51(1-2):17-23. PubMed ID: 10865426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Nosocomial spread of linezolid-resistant Staphylococcus hominis in two hospitals in Majorca].
    Ruiz de Gopegui E; Iuliana Marinescu C; Díaz P; Socías A; Garau M; Ayestarán JI; Pareja A; Gallegos MC; Pérez JL; Oliver A
    Enferm Infecc Microbiol Clin; 2011 May; 29(5):339-44. PubMed ID: 21435748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of linezolid and daptomycin against methicillin-resistant coagulase-negative staphylococci with increased MIC for vancomycin isolated from blood cultures in pediatric patients.
    Castagnola E; Amoroso L; Banov L; Faraci M; Loy A; Moscatelli A; Risso F; Barabino P; Ciucci A; Bandettini R
    J Chemother; 2014 Oct; 26(5):273-5. PubMed ID: 24070064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative in vitro activity of glycopeptides against coagulase negative staphylococci isolated in pediatric hospital units].
    Bourgeois F; Bingen E; Lambert-Zechovsky N
    Pathol Biol (Paris); 1992 Jan; 40(1):36-9. PubMed ID: 1533278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of teicoplanin and vancomycin in vitro activity on clinical isolates of Staphylococcus aureus.
    Tascini C; Flammini S; Leonildi A; Ciullo I; Tagliaferri E; Menichetti F
    J Chemother; 2012 Aug; 24(4):187-90. PubMed ID: 23040680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of susceptibility of methicillin resistant Staphylococcus aureus strains to vancomycin].
    Młynarczyk G; Młynarczyk A; Meisel-Mikołajczyk F
    Med Dosw Mikrobiol; 1995; 47(3-4):133-9. PubMed ID: 8833924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus.
    Morales G; Picazo JJ; Baos E; Candel FJ; Arribi A; Peláez B; Andrade R; de la Torre MA; Fereres J; Sánchez-García M
    Clin Infect Dis; 2010 Mar; 50(6):821-5. PubMed ID: 20144045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
    Drago L; Nicola L; De Vecchi E
    Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activities of vancomycin and linezolid against biofilm-producing methicillin-resistant staphylococci species isolated from catheter-related bloodstream infections from an Egyptian tertiary hospital.
    Hashem AA; Abd El Fadeal NM; Shehata AS
    J Med Microbiol; 2017 Jun; 66(6):744-752. PubMed ID: 28598310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro activity of linezolid against clinical isolates of methicillin-resistant Staphylococcus aureus].
    Pérez L; Alarcón T; Jiménez S; de Las Cuevas MC; López-Brea S
    Rev Esp Quimioter; 2001 Mar; 14(1):47-50. PubMed ID: 11376349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicenter evaluation of the in vitro activity of dalbavancin tested against staphylococci and streptococci in 5 European countries: results from the DECIDE Surveillance Program (2007).
    Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):177-84. PubMed ID: 19249179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant Staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast Italy.
    Cojutti P; Scarparo C; Sartor A; Coato P; Rigoli R; Pea F
    Diagn Microbiol Infect Dis; 2015 Jan; 81(1):53-6. PubMed ID: 25301716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro activity of vancomycin and teicoplanin against gram-positive cocci].
    Bezian MC; Ribou G; Masquelier B
    Pathol Biol (Paris); 1992 May; 40(5):461-5. PubMed ID: 1386667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methicillin-resistant
    Peixoto PB; Massinhani FH; Netto Dos Santos KR; Chamon RC; Silva RB; Lopes Correa FE; Barata Oliveira CDCH; Oliveira AG
    J Med Microbiol; 2020 Jan; 69(1):41-45. PubMed ID: 31789588
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro susceptibility of Gram-positive pathogens to linezolid and teicoplanin and effect on outcome in critically ill patients.
    Wilson AP; Cepeda JA; Hayman S; Whitehouse T; Singer M; Bellingan G
    J Antimicrob Chemother; 2006 Aug; 58(2):470-3. PubMed ID: 16735420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An international activity and spectrum analysis of linezolid: ZAAPS Program results for 2011.
    Flamm RK; Mendes RE; Ross JE; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):206-13. PubMed ID: 23478031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 79.